证券记录 · 已归档季度
EXAS
Exact Sciences Corporation · Healthcare · Medical - Diagnostics & Research
18被追踪持有人
—Δ持有人
42.26M持有股份
$1.79B报告持仓市值
+0新建仓位
−0清仓
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q1 2026 | 1 | -143 | 11.48K | $1.20M | — | −144 |
| Q4 2025 | 146 | +2 | 107.45M | $10.91B | +5 | −2 |
| Q3 2025 | 23 | +1 | 95.08M | $5.20B | +1 | −1 |
| Q2 2025 | 20 | 0 | 105.61M | $5.61B | — | — |
| Q1 2025 | 17 | -2 | 51.51M | $2.23B | +1 | −3 |
| Q4 2024 | 19 | +2 | 51.81M | $2.91B | +3 | −1 |
| Q3 2024 | 16 | -2 | 41.47M | $2.82B | — | −2 |
| Q2 2024 | 18 | — | 42.26M | $1.79B | — | — |
持有人 · Q2 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Capital World Investors ✦ | 16.50M | — | $697.18M | 0.1% | n/c | 1 | SEC ↗ |
| 2 | Wellington Management ✦ | 14.79M | — | $624.81M | 0.1% | n/c | 1 | SEC ↗ |
| 3 | Wellington Management ✦ | 14.79M | — | $624.81M | 0.1% | n/c | 1 | SEC ↗ |
| 4 | Wellington Management ✦ | 14.79M | — | $624.81M | 0.1% | n/c | 1 | SEC ↗ |
| 5 | Wellington Management ✦ | 14.79M | — | $624.81M | 0.1% | n/c | 1 | SEC ↗ |
| 6 | Wellington Management ✦ | 14.79M | — | $624.81M | 0.1% | n/c | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 14.79M | — | $624.81M | 0.1% | n/c | 1 | SEC ↗ |
| 8 | Wellington Management ✦ | 14.79M | — | $624.81M | 0.1% | n/c | 1 | SEC ↗ |
| 9 | Geode Capital Management ✦ (被动) | 3.10M | — | $130.68M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Geode Capital Management ✦ (被动) | 3.10M | — | $130.68M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Baillie Gifford ✦ | 1.43M | — | $60.27M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Baillie Gifford ✦ | 1.43M | — | $60.27M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Baillie Gifford ✦ | 1.43M | — | $60.27M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Baillie Gifford ✦ | 1.43M | — | $60.27M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Norges Bank ✦ (被动) | 1.24M | — | $52.48M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 1.19M | — | $50.07M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 1.19M | — | $50.07M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Millennium Management ✦ | 674.86K | — | $28.51M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Glenview Capital ✦ | 629.46K | — | $26.59M | 0.6% | n/c | 1 | SEC ↗ |
| 20 | Renaissance Technologies ✦ | 510.70K | — | $21.58M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | PRIMECAP Management ✦ | 496.30K | — | $20.97M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Citadel Advisors ✦ | 461.34K | — | $19.49M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Citadel Advisors ✦ | 461.34K | — | $19.49M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | ARK Investment Management ✦ | 344.49K | — | $14.55M | 0.1% | n/c | 1 | SEC ↗ |
| 25 | Soros Fund Management ✦ | 225.00K | — | $9.51M | 0.3% | n/c | 1 | SEC ↗ |
| 26 | Point72 Asset Management ✦ | 195.77K | — | $8.27M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Fisher Asset Management ✦ | 159.20K | — | $6.73M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | AQR Capital Management ✦ | 153.60K | — | $6.49M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | AQR Capital Management ✦ | 153.60K | — | $6.49M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | AQR Capital Management ✦ | 153.60K | — | $6.49M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | AQR Capital Management ✦ | 153.60K | — | $6.49M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | Gotham Asset Management ✦ | 131.55K | — | $5.56M | 0.1% | n/c | 1 | SEC ↗ |
| 33 | D. E. Shaw & Co. ✦ | 40.25K | — | $1.70M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | D. E. Shaw & Co. ✦ | 40.25K | — | $1.70M | 0.0% | n/c | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 9 持有人, 64.35K 股份, $4.50M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2024 ·
方法论 ·
通过API获取此数据